Institute for Neurodegenerative Disorders seeks study volunteers with Alzheimer’s disease
ICARA Study to evaluate safety and effectiveness of an investigational drug for controlling progression of Alzheimer’s disease
The Institute for Neurodegenerative Disorders is participating in ICARA (Investigational Clinical Amyloid Research in Alzheimer’s) – an international clinical study to learn if an investigational drug can help control the progression of Alzheimer’s disease. In total, approximately 2050 patients will be enrolled at research sites in North America. More
Nov 19, 2008 - 6:12 AM
|
|